A toxicology journal has retracted a 16-year-old study linking hepatitis B vaccines to autism in children following an independent statistical review that found a half-dozen concerns with the study’s methodology.
Using data from the National Health Interview Survey, the authors claimed boys vaccinated in their first month of life had “threefold greater odds for autism diagnosis” than those vaccinated later or not at all.
The study was included in a rapid systematic review of hep B vaccine studies presented by John Su, director of the Immunization Safety Office for the Centers for Disease Control and Prevention, at the Sept. 18 meeting of the Advisory Committee on Immunization Practices. It resurfaced in a presentation at the Dec. 4 ACIP meeting, just before the committee’s decision to no longer recommend that infants receive the hep B vaccine at birth if the mother tests negative for the virus.
Continue reading Journal retracts study linking hepatitis vaccine to autism that was included in CDC review







